{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:17:03Z","timestamp":1773080223233,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,17]]},"DOI":"10.7759\/cureus.97112","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:51:36Z","timestamp":1763441496000},"source":"Crossref","is-referenced-by-count":1,"title":["Infliximab-Induced Autoimmune Phenomenon in an Adolescent With Ulcerative Colitis: Drug-Induced Lupus vs Inflammatory Myositis"],"prefix":"10.7759","author":[{"given":"Nika","family":"Bakshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya S","family":"Kardouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Kriem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"UpToDate. Management of moderate to severe ulcerative colitis in adults. (2025). Accessed: October 25, 2025: https:\/\/www.uptodate.com\/contents\/management-of-moderate-to-severe-ulcerative-colitis-in-adults.","DOI":"10.18773\/austprescr.2025.004"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13554-012-0006-1","article-title":"Pediatric ulcerative colitis: the therapeutic road to infliximab","volume":"3","author":"Puthoor PR","year":"2013","unstructured":"Puthoor PR, de Zoeten EF. Pediatric ulcerative colitis: the therapeutic road to infliximab. Biol Ther. 2013, 3:1-14. 10.1007\/s13554-012-0006-1","journal-title":"Biol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000001349","article-title":"Infliximab-induced optic perineuritis and facial myositis","volume":"42","author":"Mukharesh L","year":"2022","unstructured":"Mukharesh L, Tinsley A. Infliximab-induced optic perineuritis and facial myositis. J Neuroophthalmol. 2022, 42:e583-5. 10.1097\/WNO.0000000000001349","journal-title":"J Neuroophthalmol"},{"key":"ref4","article-title":"Tumor necrosis factor inhibitors","author":"Gerriets V","year":"2023","unstructured":"Gerriets V, Goyal A, Khaddour K. Tumor necrosis factor inhibitors. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2015.11.001","article-title":"Sarcoidosis patient with lupus pernio and infliximab-induced myositis: response to Acthar gel","volume":"17","author":"Zhou Y","year":"2016","unstructured":"Zhou Y, Lower EE, Li H, Baughman RP. Sarcoidosis patient with lupus pernio and infliximab-induced myositis: response to Acthar gel. Respir Med Case Rep. 2016, 17:5-7. 10.1016\/j.rmcr.2015.11.001","journal-title":"Respir Med Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/20101058221147755","article-title":"Anti-tumor necrosis factor-induced focal myositis","volume":"31","author":"Masnammany AM","year":"2022","unstructured":"Masnammany AM, Lau W, Wong PK, Manolios N. Anti-tumor necrosis factor-induced focal myositis. Proc Singapore Healthc. 2022, 31:10.1177\/20101058221147755","journal-title":"Proc Singapore Healthc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2020.1800958","article-title":"Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis","volume":"5","author":"Yoshida A","year":"2021","unstructured":"Yoshida A, Katsumata Y, Hirahara S, Hanaoka M, Ochiai M, Kobayashi M, Harigai M. Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis. Mod Rheumatol Case Rep. 2021, 5:156-61. 10.1080\/24725625.2020.1800958","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref8","article-title":"Juvenile dermatomyositis","author":"Gara S","year":"2023","unstructured":"Gara S, Jamli RT, Muse ME, Litaeim N. Juvenile dermatomyositis. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref9","article-title":"Drug-induced lupus","author":"Merola JF","year":"2025","unstructured":"Merola JF. Drug-induced lupus. UpToDate. Pisetsky DS, Callen JP, Case SM (ed): UpToDate, Inc., Waltham (MA); 2025."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434063-infliximab-induced-autoimmune-phenomenon-in-an-adolescent-with-ulcerative-colitis-drug-induced-lupus-vs-inflammatory-myositis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:51:37Z","timestamp":1763441497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434063-infliximab-induced-autoimmune-phenomenon-in-an-adolescent-with-ulcerative-colitis-drug-induced-lupus-vs-inflammatory-myositis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.97112","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}